Invention Grant
- Patent Title: Inhibitors of leukotriene A4 hydrolase
-
Application No.: US15704199Application Date: 2017-09-14
-
Publication No.: US10399986B2Publication Date: 2019-09-03
- Inventor: William Guilford
- Applicant: CELTAXSYS, INC.
- Applicant Address: US GA Atlanta
- Assignee: Celtaxsys, Inc.
- Current Assignee: Celtaxsys, Inc.
- Current Assignee Address: US GA Atlanta
- Agency: Elmore Patent Law Group, P.C.
- Agent Mahreen Chaudhry-Hoda; Carolyn S. Elmore
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
The present invention is directed to compounds encompassed by the Formula (I): pharmaceutical compositions thereof, methods for inhibiting LTA-4 hydrolase, and methods for the treatment of a disease and disorder which is ameliorated by the inhibition of LTA4h activity. Non-limiting examples of such diseases and conditions include inflammatory and autoimmune diseases and disorders.
Public/Granted literature
- US20180127424A1 INHIBITORS OF LEUKOTRIENE A4 HYDROLASE Public/Granted day:2018-05-10
Information query
